We want to test the effects of Sartans+Statins combinations in small therapeutic doses on the condition of vessel. Positive results will indicate a reduced risk of CVD in the near future and postponed pathologies development, which will become a direct opportunity to increase individual life expectancy.
A recently published article
on biomarkers of aging has confirmed the right choice of indicators to measure. Researchers have shown that IL-6, C-reactive protein and cystatin C, which we have also chosen, grow with age. Adding intima-media thickness (IMT) to this list, we get the optimal biomarkers panel for this research.